Androgen deprivation therapy for prostate cancer, measures of adiposity and strength, and adverse cardiovascular outcomes: observations from 3000 men in 5 countries in the RADICAL PC study

28 August 2023 (08:48 - 09:06)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Darryl Leong

Population Health Research Institute, Hamilton (Canada)

4 More presentations in this session

Presentation thumbnail

State-of-the-art lecture on prediction and management of cardiovascular risk in cancer patients

Doctor A. Lyon (London, GB)

Presentation thumbnail

Risk prediction model of cardiotoxicity in breast cancer patients; the multicenter prospective CHECK HEART-BC (comprehensive heart imaging to evaluate cardiac damage linked with chemotherapy in breast

Doctor Y. Terui (Sendai, JP)

Abstract Slides Video

Presentation thumbnail

Right ventricular free wall strain and tricuspid annular plane systolic excursion for the prediction of left sided cardiotoxicity in lymphoma patients treated with anthracycline-based chemotherapy.

Doctor C. Ricaurte Carmona (Rochester, US)

Abstract Slides Video

Presentation thumbnail

Clinical features and long-term outcomes of cancer-associated venous thromboembolism: transition from the warfarin era to the direct oral anticoagulant era

Doctor R. Chatani (Kurashiki, JP)

Abstract Slides Video

Access the full session

Session thumbnail

Prediction and management of cardiovascular risk for patients with cancer

The Event

Event poster

ESC Congress 2023

28 August 2023 08:48 CET

You may be interested in

Congress Presentation

A male prostate cancer survivor

Congress Presentation

Cardiovascular issues in male patients receiving hormonal therapies / Problematiche cardiovascolari in uomini in terapia ormonale

Congress Session

Continuous cardiovascular prevention in cancer care

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources